
(Updated - February 5, 2024 11:47 AM EST)
Investing.com -- Main U.S. indexes declined Monday as higher bond yields weighed on sentiment and investors continued to trim bets on a March rate cut from the Fed following comments from Chairman Powell and other officials.
Here are some of the biggest U.S. stock movers today:
Shares in Boeing (NYSE:BA) fell 1.6% after the embattled planemaker warned that a fresh issue in some fuselages of its 737 jets could lead to the "near-term" delivery delays.
McDonald's (NYSE:MCD) fell 3.5% after reporting fourth-quarter sales growth that missed Wall Street estimates as violence in the Middle East dented its overseas operations. But the burger chain predicted that it would register operating margin in the "mid- to high-40%" range in 2024, implying an improvement versus the prior year's mark of 45.7% at the upper-end of the guidance.
Caterpillar (NYSE:CAT), the machinery manufacturer that is often viewed as a bellwether for the American industrial sector, gained 1.3% after it posted fourth-quarter adjusted per-share profit that topped expectations, as higher prices helped offset a dip in sales volume. Shares in the company rose in premarket U.S. dealmaking.
Catalent (NYSE:CTLT) shares jumped 9.8% after Novo Nordisk-parent Novo Holdings agreed to buy the contract drugmaker for $11.5 billion.
Estee Lauder 's (NYSE:EL) stock price surged 13% after the beauty products group announced plans to cut as many as 3,000 roles as part of a broader restructuring push.
Everbridge (NASDAQ:EVBG) shares rose 18% after the software company said it would be bought by U.S. private equity firm Thoma Bravo in an all-cash deal worth about $1.5 billion.
Cano Health (CANO) declined and was later halted after primary care provider filed for Chapter 11 bankruptcy late on Sunday.
Haynes International (NASDAQ:HAYN) gained 6% after the corrosion-resistant alloy producer agreed to be bought by Spanish steelmaker Acerinox.
Air Products and Chemicals (NYSE:APD) stock dipped 14% after the company posted weaker-than-anticipated first-quarter profit and reduced its annual adjusted earnings per share guidance.
Onsemi (ON) stock rose 8% after the semiconductor manufacturer posted better-than-expected fourth-quarter earnings and revenue. Outlook missed estimates but was better than feared, analysts said.
Zscaler (NASDAQ:ZS) stock fell 5.4% after the company announced the departure of its Chief Operating Officer. The change was seen as a significant executive leadership shake-up.
GlobalFoundries (NASDAQ:GFS) declined 5% after JPMorgan downgraded the stock to ‘neutral’ from ‘overweight’ with a price target of $56.00 (from $65.00). Analysts think the stock will perform, at best, line-line with peers.
Eli Lilly (NYSE:LLY) climbed 5.8% on reports its diabetes drug Mounjaro is in short supply. Mounjaro’s sister drug Zepbound has the same active ingredient and is approved for weight loss but it is not listed on the FDA’s database.
MorphoSys AG (MOR) climbed 40% following a report from Reuters that said drug maker Novartis (SIX:NOVN) (NVS) is in advanced talks to acquire the company.
Tesla (NASDAQ:TSLA) declined another 5%, extending its 30-day slump to 25%. Its status as a so-called "magnificent seven" stock is in doubt.
Additional reporting by Louis Juricic
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.